Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2025

10 Dec 2025
Appendix 2A – Application for quotation of securities
10 Dec 2025
Appendix 2A – Application for quotation of securities
10 Dec 2025
Appendix 3G – Notification of issue, conversion or payment up of unquoted equity securities
10 Dec 2025
Completion of acquisition of Sedarex Limited
2 Dec 2025
Completion of Tranche 2 of Placement
2 Dec 2025
Notification of issue, conversion or payment up of unquoted equity securities
2 Dec 2025
Notification of issue, conversion or payment up of unquoted equity securities
2 Dec 2025
Application for quotation of securities
26 Nov 2025
Dispatch of prospectus and offer open
19 Nov 2025
Rounding of fractions of attaching options
18 Nov 2025
Non-Renounceable Rights Issue Prospectus
17 Nov 2025
Results of Annual General Meeting
17 Nov 2025
Chairman’s address to the AGM
14 Nov 2025
Hepatitis B Virus Program Update
11 Nov 2025
Shareholder update
11 Nov 2025
Presentation to investors
7 Nov 2025
Biotron Investor Webinar
30 Oct 2025
Report on activities for the quarter ended 30 September 2025
17 Oct 2025
Annual Report and Notice of AGM
15 Oct 2025
Appendix 3B – Proposed issue of securities – Facilitation shares
15 Oct 2025
Appendix 3B – Proposed issue of securities – Broker options
15 Oct 2025
Appendix 3B – Proposed issue of securities – Acquisition
15 Oct 2025
Appendix 3B – Proposed issue of securities – Placement
15 Oct 2025
Biotron Investor Webinar
15 Oct 2025
Presentation to investors
15 Oct 2025
Acquisition of Sedarex Limited and $2.5m capital raising
29 Sep 2025
Biotron 2025 AGM – Notification Dates
2 Sep 2025
Year end accounts and preliminary final report
29 Jul 2025
Quarterly Report 30 June 2025
16 Jul 2025
Appointment of Non-Executive Director
24 Jun 2025
Hepatitis B Virus Program Update
16 Jun 2025
Change of Share Registry Address
2 May 2025
Change of Company Secretary
24 Apr 2025
Report on activities for the quarter ended 31 March 2025
10 Apr 2025
Director’s Interests
8 Apr 2025
Successful completion of the entitlement offer
13 Mar 2025
Update on Rights Issue Timetable
12 Mar 2025
Appendix 3B Update – Proposed issue of securities
12 Mar 2025
Response to ASX query letter dated 7 March 2025
12 Mar 2025
Replacement Prospectus
10 Mar 2025
Appendix 3B Update – Proposed issue of securities
10 Mar 2025
Delay in Offer Opening
5 Mar 2025
Appendix 3B proposed issue of securities new timetable
5 Mar 2025
Supplementary Prospectus
5 Mar 2025
Commencement of rights trading on ASX
4 Mar 2025
Response to ASX aware letter dated 26 February 2025
3 Mar 2025
Prospectus
3 Mar 2025
Half-year Report 31 December 2024
28 Feb 2025
Change of Address
28 Feb 2025
Cancellation of Proposed Issue of Securities
28 Feb 2025
Proposed Issue of Securities
28 Feb 2025
Renounceable Rights Issue
26 Feb 2025
Biotron Investor Webinar
21 Feb 2025
Appendix 3B – SPP
21 Feb 2025
Offer Document
21 Feb 2025
Letter to Shareholders
3 Feb 2025
Quarterly Report 31 December 2024
3 Feb 2025
Report on Activities for the Quarter Ended 31 Dec 2024

2025
2024

2023

2022

2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 12 December 2025 Legal Notices and Privacy